Average Co-Inventor Count = 7.24
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (10 from 1,168 patents)
2. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)
3. Other (1 from 832,680 patents)
4. Smithkline Beecham Corporation (1 from 2,198 patents)
5. Glaxosmithkline Intellectual Property (no.2) Limited (1 from 92 patents)
6. Glaxosmithkline Intellectual Property Limited (0 patent)
15 patents:
1. 10815218 - Benzoimidazole derivatives as PAD4 inhibitors
2. 10407407 - Benzoimidazole derivatives as PAD4 inhibitors
3. 10039755 - 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
4. 9833449 - 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
5. 9670221 - Furopyridines as bromodomain inhibitors
6. 9518054 - 2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
7. 9447074 - Compounds
8. 9127003 - 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors
9. 8993560 - Compounds
10. 8633319 - 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors
11. 7985740 - Purine derivatives as agonists of the adenosine A2A receptor
12. 7572915 - Quinoline derivatives as phosphodiesterase inhibitors
13. 7566786 - Quinoline derivatives as phosphodiesterase inhibitors
14. 6528494 - 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
15. 6426337 - 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives